Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles (2023 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Amortizatization of Intangibles came in at $77000.0 in Q1 2026, down 31.25% year-on-year from $112000.0 in Q1 2025, and down 75.94% on a QoQ basis from $320000.0 in Q4 2025.
Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 4 years of Amortizatization of Intangibles data on file, last reported at $77000.0 in Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 31.25% year-over-year to $77000.0 in Q1 2026; TTM through Mar 2026 was $776000.0, a 24.22% decrease from a year earlier, with the FY2025 full-year figure at $811000.0, down 45.97% from the prior year.
- Amortizatization of Intangibles for Q1 2026 stood at $77000.0, down from $320000.0 in the prior quarter.
- Over the last five years, Amortizatization of Intangibles for OBIO reached as high as $1.1 million in Q3 2023 and fell as low as $49000.0 in Q2 2025.
- Historically, Amortizatization of Intangibles has averaged $477538.5 across 4 years, with a median of $330000.0 in 2025.
- On a YoY basis, Amortizatization of Intangibles climbed as much as 38.53% in 2025 and fell as far as 84.92% in 2025.
- Year by year, Amortizatization of Intangibles stood at $638000.0 in 2023, then plunged by 63.79% to $231000.0 in 2024, then soared by 38.53% to $320000.0 in 2025, then plunged by 75.94% to $77000.0 in 2026.
- Per Business Quant data, the three most recent Amortizatization of Intangibles figures were $77000.0 in Q1 2026, $320000.0 in Q4 2025, and $330000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | Orchestra BioMed Holdings | 240.54 Mn | 146.14 Mn | 78,000.00 | 77,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 77,000.00 |
| Mar 31, 2026 | 77,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Dec 31, 2025 | 320,000.00 |
| Sep 30, 2025 | 330,000.00 |
| Sep 30, 2025 | 330,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Jun 30, 2025 | 49,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Mar 31, 2025 | 112,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Dec 31, 2024 | 231,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Sep 30, 2024 | 356,000.00 |
| Jun 30, 2024 | 325,000.00 |
| Jun 30, 2024 | 325,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Mar 31, 2024 | 589,000.00 |
| Dec 31, 2023 | 638,000.00 |
| Dec 31, 2023 | 638,000.00 |